BioMed Research International

Physiology to the Pleiotropic Role of RNAs: Prospecting Novel Therapies


Status
Published

1INSERM U848, Institute Gustave Roussy, Villejuif, France

2IERFC, Ospedale San Raffaele, Milano, Italy

3Laboratory for Translational Oncology and Personalized Medicine, Rashid Latif Medical College, Lahore, Pakistan


Physiology to the Pleiotropic Role of RNAs: Prospecting Novel Therapies

Description

A growing number of functions are assigned to RNA. In the past decade, evidence emerged concerning the physiological and pathological roles of microRNA, short hairpin RNA, and small interfering RNA. This knowledge arises the opportunity to both consider RNAs as novel therapeutic targets and tools. It is anticipated that advancement in this direction will depict a new landscape for treating several human diseases.

We invite authors to submit original research and review articles that deepen the understanding of the importance of RNAs in physiopathological contexts. Potential topics include, but are not limited to:

  • RNAs’ structural characterization and function
  • RNAs-induced posttranscriptional/translational and epigenetic modifications
  • RNAs’ role and application in human diseases
  • Strategies for pharmacokinetics/delivery approaches

Before submission authors should carefully read over the journal’s Author Guidelines, which are located at http://www.hindawi.com/journals/bmri/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/submit/journals/bmri/physiology/pleio/ according to the following timetable:


Articles

  • Special Issue
  • - Volume 2014
  • - Article ID 735374
  • - Editorial

Physiology to the Pleiotropic Role of RNAs: Prospecting Novel Therapies

Maria Chiara Maiuri | Daniela De Stefano | Ammad Ahmad Farooqi
  • Special Issue
  • - Volume 2014
  • - Article ID 718743
  • - Research Article

Inhibition of Hepatitis B Virus Replication by Helper Dependent Adenoviral Vectors Expressing Artificial Anti-HBV Pri-miRs from a Liver-Specific Promoter

Mohube Betty Mowa | Carol Crowther | ... | Patrick Arbuthnot
  • Special Issue
  • - Volume 2014
  • - Article ID 418628
  • - Research Article

Systemic Approach to Identify Serum microRNAs as Potential Biomarkers for Acute Myocardial Infarction

An Hsu | Shu-Jen Chen | ... | Pao-Hsien Chu
  • Special Issue
  • - Volume 2014
  • - Article ID 610718
  • - Research Article

Exploitation of a Very Small Peptide Nucleic Acid as a New Inhibitor of miR-509-3p Involved in the Regulation of Cystic Fibrosis Disease-Gene Expression

Felice Amato | Rossella Tomaiuolo | ... | Giuseppe Castaldo
  • Special Issue
  • - Volume 2014
  • - Article ID 798918
  • - Research Article

Rapid Degradation of Hfq-Free RyhB in Yersinia pestis by PNPase Independent of Putative Ribonucleolytic Complexes

Zhongliang Deng | Zizhong Liu | ... | Yanping Han
  • Special Issue
  • - Volume 2014
  • - Article ID 901617
  • - Research Article

Synthesis and Gene Silencing Properties of siRNAs Containing Terminal Amide Linkages

Maria Gaglione | M. Emilia Mercurio | ... | Anna Messere
  • Special Issue
  • - Volume 2014
  • - Article ID 217365
  • - Research Article

Transferrin-Conjugated SNALPs Encapsulating 2′-O-Methylated miR-34a for the Treatment of Multiple Myeloma

Immacolata Scognamiglio | Maria Teresa Di Martino | ... | Giuseppe De Rosa
BioMed Research International
 Journal metrics
Acceptance rate30%
Submission to final decision66 days
Acceptance to publication36 days
CiteScore3.600
Impact Factor2.276
 Submit

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.